BPA Call 36C25021A0051-36C25021N0309
- This is a Firm Fixed Price BPA Call contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $113,618.48, is for the supply of HPV testing equipment, supplies, and maintenance services for the second option year. The contract is not set-aside. Roche Diagnostics has previously received awards from the VA, Department of Defense,...
- This is a $126,006.07 firm fixed price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory equipment, and supplies. The contract is to provide Human Papillomavirus (HPV) testing equipment, supplies, and preventative maintenance services for a 5-year period through February 2026. This order is placed against Roche's critical analyzers laboratory equipment...
- This is a $54,442.32 firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is for the provision of HPV testing equipment, supplies, and preventive maintenance services, with a period of performance through February 4, 2023. This delivery order was placed against a master Blanket Purchase Agreement (BPA) held by Roche under the General Services Administration (GSA) Critical...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a Blanket Purchase Agreement (BPA) call placed by the U.S. Department of Veterans Affairs (VA) for HPV testing equipment, supplies, and preventative maintenance option year 3. The award ceiling value is $84,142.60 and the contract is a Firm Fixed Price arrangement under the VA's Critical Analyzers, Laboratory Master Contract (FSS-66-III) on the General Services Administration (GSA)...
- This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call award from the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $150,000.00, is for the delivery of reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing. The place of performance is Castleton,...
- This is a $170,904.26 Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The contract is for the delivery of reagents and consumables for human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG) testing. The contract has a period of performance through September 30, 2024 and is a firm fixed-price arrangement. This BPA...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2, is for HPV detection cost-per-test services during the option year 1 period. The contract has a ceiling value of $105,293.00 and is a firm fixed price Blanket Purchase Agreement (BPA) call order. The...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $109,715.20, is for the provision of reagents and consumables for HPV, chlamydia, and gonorrhea testing. The award does not have a set-aside designation, indicating open...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) Call awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical products. The contract, valued at $168,800.24, is for the delivery of reagents and consumables for HPV, Chlamydia, and Gonorrhea (HPV/CT/NG) testing. The contract has an ultimate completion date of November 30, 2024 and is not designated as a set-aside. Roche...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of a Roche HPV/HIV analyzer and related test kits, with a ceiling value of $64,386.51 and a performance period through December 17, 2023. The award was not set aside for any...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797D70105-36C25021A0051Blanket Purchase Agreement
- 36C25021A0051-36C25021N0309BPA Call
This is a $77,704.92 Firm Fixed Price BPA Call contract awarded by the Veterans Integrated Service Network 10 of the Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide HPV testing equipment, supplies, and preventative maintenance through the critical analyzers, laboratory equipment GSA Schedule contract. The award has no set-aside designation. Roche Diagnostics provides a variety of medical devices, reagents, and laboratory equipment and services to federal agencies including the VA, DOD, HHS, USDA, and DOC through GSA Schedules and IDV contracts. This award establishes a vehicle for the VA to acquire HPV testing capabilities and associated maintenance on an as-needed basis over the contract's 1-year period of performance.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($48k) | 7/12/22 | |
| P00001 | Funding Only Action | $47.4k | 3/31/21 | |
| Not listed | Not listed | $78.6k | 2/5/21 |